"Contraceptives, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
| Descriptor ID |
D003276
|
| MeSH Number(s) |
D27.505.696.875.360.276.210 D27.505.954.705.360.276.210
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Contraceptives, Oral".
Below are MeSH descriptors whose meaning is more specific than "Contraceptives, Oral".
This graph shows the total number of publications written about "Contraceptives, Oral" by people in this website by year, and whether "Contraceptives, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Contraceptives, Oral" by people in Profiles.
-
Inflammatory breast cancer: early recognition and diagnosis is critical. Am J Obstet Gynecol. 2021 10; 225(4):392-396.
-
Combination of 4-HPR and oral contraceptive in monkey model of chemoprevention of ovarian cancer. Front Biosci. 2007 Jan 01; 12:2260-8.
-
Specific keynote: chemoprevention of ovarian cancer: the journey begins. Gynecol Oncol. 2003 Jan; 88(1 Pt 2):S59-66; discussion S67-70.
-
Fluorescence spectroscopy as a biomarker in a cell culture and in a nonhuman primate model for ovarian cancer chemopreventive agents. J Biomed Opt. 2002 Jan; 7(1):20-6.
-
Biomarker modulation in a nonhuman rhesus primate model for ovarian cancer chemoprevention. Cancer Epidemiol Biomarkers Prev. 2001 Aug; 10(8):889-93.
-
Special considerations in breast cancer risk and survival. J Surg Oncol. 1999 Aug; 71(4):250-60.
-
Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol. 1997 May; 176(5):1017-25.
-
[13C]Aminopyrine breath test detects altered liver metabolism caused by low-dose oral contraceptives. Dig Dis Sci. 1995 Nov; 40(11):2417-22.
-
Hepatic adenoma: a possible complication of oral contraceptive therapy. South Med J. 1976 Jun; 69(6):683-7.